We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$1.1B 6.65%
2,455,167
-4,721
-0.2% -$1.99M
NVDA icon
2
NVIDIA
NVDA
$5.02T
$849M 5.14%
6,869,370
+11,580
+0.2% +$1.17M
AAPL icon
3
Apple
AAPL
$4.81T
$749M 4.54%
3,555,963
-218,768
-6% -$40.8M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.24T
$556M 3.37%
3,054,379
-1,335
-0% -$225K
LLY icon
5
Eli Lilly
LLY
$1.02T
$440M 2.66%
485,616
+75,079
+18% +$60.1M
MRK icon
6
Merck
MRK
$312B
$295M 1.79%
2,380,465
-92,865
-4% -$12M
AMZN icon
7
Amazon
AMZN
$2.66T
$290M 1.76%
1,501,076
+253,352
+20% +$46.5M
TMO icon
8
Thermo Fisher Scientific
TMO
$195B
$239M 1.45%
431,658
+4,571
+1% +$2.62M
UNH icon
9
UnitedHealth
UNH
$396B
$229M 1.39%
450,366
+58,014
+15% +$28.4M
V icon
10
Visa
V
$686B
$218M 1.32%
831,372
+39,568
+5% +$10.8M
REGN icon
11
Regeneron Pharmaceuticals
REGN
$70.5B
$211M 1.28%
200,708
-17,063
-8% -$16.5M
AMGN icon
12
Amgen
AMGN
$198B
$191M 1.16%
610,168
-78,192
-11% -$23M
PG icon
13
Procter & Gamble
PG
$345B
$184M 1.11%
1,113,867
+58,360
+6% +$9.54M
MA icon
14
Mastercard
MA
$484B
$182M 1.1%
413,193
+19,480
+5% +$8.87M
GOOG icon
15
Alphabet (Google) Class C
GOOG
$4.22T
$175M 1.06%
951,984
+1,055
+0.1% +$179K
AMAT icon
16
Applied Materials
AMAT
$448B
$160M 0.97%
676,556
+50,571
+8% +$10.9M
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$122B
$154M 0.93%
328,271
-60,317
-16% -$26.2M
AVGO icon
18
Broadcom
AVGO
$1.84T
$151M 0.92%
941,760
+21,940
+2% +$3.07M
TSM icon
19
TSMC
TSM
$2.2T
$140M 0.85%
803,095
+13,325
+2% +$2.02M
GILD icon
20
Gilead Sciences
GILD
$165B
$139M 0.84%
2,019,920
-265,209
-12% -$17.7M
WM icon
21
Waste Management
WM
$96B
$135M 0.82%
634,190
-5,606
-0.9% -$1.17M
NOW icon
22
ServiceNow
NOW
$105B
$134M 0.81%
850,785
-4,800
-0.6% -$704K
CRM icon
23
Salesforce
CRM
$139B
$132M 0.8%
512,334
-88,037
-15% -$23.6M
HD icon
24
Home Depot
HD
$332B
$131M 0.8%
381,541
+75,564
+25% +$25.8M
MU icon
25
Micron Technology
MU
$1.1T
$127M 0.77%
962,683
-41,014
-4% -$5.17M

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.